Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke

Patent foramen ovale (PFO) is a potential cause of cryptogenic stroke. Three previous randomized trials of transcatheter PFO closure did not show a lower risk of recurrent stroke with PFO closure than with medical therapy in their primary intention-to-treat analyses; however, secondary analyses…

http://ift.tt/2xn0icH